Clinical Trial Update: A Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Osteoarthritis of the Knee [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating the safety and preliminary efficacy of REGN475 (SAR164877) in patients with osteoarthritis of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• REGN475 (SAR164877) (SAR164877)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Osteoarthritis of the Knee | Phase 1, Phase 2 | Status: COMPLETED